Shipments come on the heels of a severe flu season and record deaths in children.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
An outbreak of an unknown febrile illness that initially prompted suspicion for hemorrhagic fever or Middle East respiratory syndrome coronavirus (MERS-CoV) has been diagnosed as dengue fever, the World Health Organization (WHO) said yesterday in a statement.
Health officials in China's Guangdong province today reported a fatal H7N9 avian influenza infection in a 42-year-old man, according to a health department statement translated and posted by FluTrackers, an infectious disease news message board.
Avian influenza viruses with components similar to those in the 1918 pandemic flu virus still circulate in nature, and genetic engineering experiments suggest it would take only a few mutations to turn them into a human threat, according to a team of scientists led by Yoshiro Kawaoka, DVM, PhD, of the University of Wisconsin.
Most Northern Hemisphere countries are at or approaching interseasonal flu levels, with North America and eastern Asia still reporting some influenza B circulation, the World Health Organization (WHO) said in its latest global flu update.
The countries at interseasonal levels included China, with the percentage of positive flu tests low in both the northern and southern parts of the country.
US influenza activity continued its season-ending decline, with one flu-related pediatric death reported, the Centers for Disease Control and Prevention (CDC) said today in its weekly update.
The percentage of US respiratory specimens that tested positive for flu dropped from 8.7% to 6.5% last week. The percentage of clinic visits for flu fell stayed even at 1.3%, well below the national baseline of 2.2%.
The Caribbean chikungunya outbreak grew by 6,303 cases in the past week to reach 63,489 suspected, probable, or confirmed cases, according to an update today from the European Centre for Disease Prevention and Control (ECDC). The count is up from 57,186 cases a week ago.
School-based flu vaccination programs may be a good vehicle for moving toward universal coverage of children, but headaches regarding billing and reimbursement issues pose big administrative challenges, says a Colorado study published in Academic Pediatrics.
Nitazoxanide, which has a different mechanism of action than neuraminidase inhibitors, could be useful alone or in combination.
In a moment that health officials have anticipated, the Florida Department of Health (FDH) today reported three cases of mosquito-borne chikungunya fever, all imported from the current 45,000-plus-case outbreak in the Caribbean.
Saying current regulations are insufficient, a German ethics panel has asked the German government to enact legislation to regulate dual-use research of concern (DURC) and set up a national committee to review DURC proposals, according to a ScienceInsider article yesterday.
